Key facts
- It has raised $250K; the latest was Early Stage VC ($250K) in May 2025.
- Notable investors include Launch Tennessee, InvestTN, Market Square Ventures, Advanced Technology Development Center.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Adele Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Adele Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Adele Health
Developer of a digital health platform designed to empower patients to take control of their diabetes. The company's platform is a combination of data and insights that empowers patients to take control of their health, and they provide cutting edge technology and advanced AI to makes it convenient for patients to see, understand, and act on their health, enabling people to make informed decisions and improve their overall well-being.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2022
- Employees
- 5
- Website
- adelehealth.com/
- Ownership
- Privately Held (backing)
Adele Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Adele Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Adele Health in its N-PORT filings yet. We sweep new filings monthly.